Tagged with M

Almirall UK The UK is leading the biotech turn, and is recognized as the largest biotech market in Europe. Why did Almirall only decide to enter this market until late 2007? Almirall was founded in 1943 in Barcelona (Spain) and in 1944 it started its industrial and commercial activity. In the 60s…

Merck Sharp & Dohme Limited (MSD) You were previously managing the Merck/Schering-Plough joint venture in the US, and arrived in the UK 2 years ago. What did you set out for yourself as head of the UK operations? As General Manager of the Merck/Schering-Plough Joint Venture in the US, I was responsible for the commercial operations…

Association of the British Pharmaceutical Industry (ABPI) Taking a look at a key achievement of the ABPI in recent years, we recognize the role you played in negotiating the revised PPRS that was put in place last year. How did the latest revision contribute to taking the research-based industry forward and what has been the impact of…

British Generic Manufacturers Association (BGMA) Together with Germany, the UK the highest generic penetration rate in Europe. Since you have been with the association since 1995 and obviously saw the great emergence of the generic medicines, can you please explain the success of generic medicines in the UK? The important aspect about the UK, which…

Association of the British Pharmaceutical Industry (ABPI) What are the priorities on your agenda as the new head of ABPI considering the successes and difficulties the association has experienced in the past? If you look at the recent history of the pharmaceutical industry in the UK, perhaps one of the areas that we have been most successful…

Promega Netherlands Promega is a truly global company with a vast international presence. What would you say is the strategic importance that the Benelux affiliate has assumed within Promega’s global network? Promega Benelux is actually the first branch office that was established outside of the US, so the company’s experience in bringing…

Medichem (Malta) Medichem began production at its plant in Malta in 2006. Can you give us a brief overview of the facilities, and of the importance of the subsidiary to Corporación Medichem as a group? Medichem was set up as a state-of-the-art facility for the manufacture of active pharmaceutical ingredients (APIs) in…

Malaysian Pharmaceutical Society (MPS) The society started at the beginning of the 20th century with the combination of the Penang Pharmaceutical Association and the Straits Pharmaceutical Association. Have there been significant shifts in the society’s objectives and what are its priorities today? For a long time, pharmacy has been a non subject. There was…

Ministry of Health (MOH) of Malaysia Would you begin by giving our readers a brief overview of the recent changes in the Ministry of Health’s focus? After Prime Minister Najib changed Malaysia’s economic policy from the ‘New Economic Policy’ to the ‘Economic Transformation Programme’ there has been a paradigm shift in the ministry’s focus. The government…

Malaysian Biotechnology Information Centre (MABIC) How would you describe MABIC today and the way that it has evolved since its creation in 2000? The Malaysian Biotech Information Centre or MABIC is an NGO and part of the ISAAA. MABIC’s central objective is to disseminate fact-based, science-based information about biotechnology to the public. The word biotechnology…

Actavis (Malta) Ltd Actavis’ Maltese operations began as far back as 1976 as a different company ( Pharmamed Ltd.). In 2001, this Malta facility was acquired by Actavis which has developed it into what is today the largest generic pharmaceutical manufacturing plant on the island. Can you give us a brief overview of…

PRIMA Can you give our readers an overview of the main characteristics of the Maltese Pharmaceutical market for innovators? Hilary Agius: In a nutshell, in Malta there are two distinct markets; the first is the private market, which is when a patient gets medication or a prescription from the doctor and…